Browsing Tag
Dreavent Capital
1 post
Astrocyte Pharmaceuticals secures over $6m for brain injury treatments
Astrocyte Pharmaceuticals Inc., a vanguard in the realm of cerebroprotective drug discovery, has amassed over $6 million in…